Biote (BTMD) FFO


BTMD Biote Corp BTMD
70 GF Score
Price $1.95
GF Value $3.07
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Biote FFO?

FFO (Funds from operations) only applies to REITs.

BTMD
70GF Score
Biote Corp BTMD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biote (BTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Biote stock appears to be undervalued. The current stock price of $1.95 is trading 36.5% below its estimated GF Value™ of $3.07. GuruFocus considers Biote to be Significantly Undervalued.

Key valuation signals for BTMD:

  • FFO:
  • GF Value™: $3.07 vs. price of $1.95 (36.5% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biote Business Description

Address 1875 W. Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
70GF Score

Get the complete analysis for BTMD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price
$3.07
GF Value